Ignite Creation Date:
2024-05-05 @ 5:26 PM
Last Modification Date:
2024-10-26 @ 9:32 AM
Study NCT ID:
NCT00459277
Status:
COMPLETED
Last Update Posted:
2012-01-25
First Post:
2007-04-10
Brief Title:
Efficacy Safety Study of Nasalfent Fentanyl Citrate Nasal Spray for Treatment of Breakthrough Cancer Pain in Patients Taking Regular Opioids
Sponsor:
Archimedes Development Ltd
Organization:
Archimedes Development Ltd
Organization Data
Organization:
Archimedes Development Ltd
Class:
INDUSTRY
Study ID:
CPO4306FCNS
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Archimedes Development Ltd
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None